NCT06363708 2024-04-12Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial CancerZhongnan HospitalPhase NA Not yet recruiting20 enrolled
NCT06039891 2023-09-15Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical CancerPeking Union Medical College HospitalPhase 2 Not yet recruiting55 enrolled